Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213066087> ?p ?o ?g. }
- W3213066087 abstract "Since the coronavirus disease outbreak in 2019, several antibody therapeutics have been developed to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Antibody therapeutics are effective in neutralizing the virus and reducing hospitalization in patients with mild and moderate infections. These therapeutics target the spike protein of SARS-CoV-2; however, emerging mutations in this protein reduce their efficiency. In this study, we developed a universal SARS-CoV-2 neutralizing antibody. We generated a humanized monoclonal antibody, MG1141A, against the receptor-binding domain of the spike protein through traditional mouse immunization. We confirmed that MG1141A could effectively neutralize live viruses, with an EC50 of 92 pM, and that it exhibited effective Fc-mediated functions. Additionally, it retained its neutralizing activity against the alpha (UK), beta (South Africa), and gamma (Brazil) variants of SARS-CoV-2. Taken together, our study contributes to the development of a novel antibody therapeutic approach, which can effectively combat emerging SARS-CoV-2 mutations." @default.
- W3213066087 created "2021-11-22" @default.
- W3213066087 creator A5008985186 @default.
- W3213066087 creator A5013471175 @default.
- W3213066087 creator A5022068424 @default.
- W3213066087 creator A5032957660 @default.
- W3213066087 creator A5035861839 @default.
- W3213066087 creator A5041262702 @default.
- W3213066087 creator A5044612550 @default.
- W3213066087 creator A5045371240 @default.
- W3213066087 creator A5048286456 @default.
- W3213066087 creator A5061875704 @default.
- W3213066087 creator A5064204310 @default.
- W3213066087 creator A5065725770 @default.
- W3213066087 creator A5067579155 @default.
- W3213066087 creator A5069064702 @default.
- W3213066087 creator A5075140229 @default.
- W3213066087 creator A5078382213 @default.
- W3213066087 creator A5083582422 @default.
- W3213066087 creator A5090258376 @default.
- W3213066087 creator A5090476083 @default.
- W3213066087 date "2021-11-18" @default.
- W3213066087 modified "2023-09-26" @default.
- W3213066087 title "MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants" @default.
- W3213066087 cites W1913949000 @default.
- W3213066087 cites W1966777137 @default.
- W3213066087 cites W1968924668 @default.
- W3213066087 cites W2001875799 @default.
- W3213066087 cites W2008286188 @default.
- W3213066087 cites W2010533241 @default.
- W3213066087 cites W2062793526 @default.
- W3213066087 cites W2068310820 @default.
- W3213066087 cites W2075097399 @default.
- W3213066087 cites W2153410165 @default.
- W3213066087 cites W2171249995 @default.
- W3213066087 cites W2310905192 @default.
- W3213066087 cites W2523571328 @default.
- W3213066087 cites W2563378637 @default.
- W3213066087 cites W2749679400 @default.
- W3213066087 cites W2762703589 @default.
- W3213066087 cites W2784885284 @default.
- W3213066087 cites W2885744227 @default.
- W3213066087 cites W2991491848 @default.
- W3213066087 cites W3004348779 @default.
- W3213066087 cites W3007643904 @default.
- W3213066087 cites W3014067025 @default.
- W3213066087 cites W3020773974 @default.
- W3213066087 cites W3022435472 @default.
- W3213066087 cites W3025744748 @default.
- W3213066087 cites W3034202401 @default.
- W3213066087 cites W3034548712 @default.
- W3213066087 cites W3039901154 @default.
- W3213066087 cites W3040899749 @default.
- W3213066087 cites W3045476609 @default.
- W3213066087 cites W3046024889 @default.
- W3213066087 cites W3084653951 @default.
- W3213066087 cites W3091944910 @default.
- W3213066087 cites W3096658347 @default.
- W3213066087 cites W3101992496 @default.
- W3213066087 cites W3111431752 @default.
- W3213066087 cites W3113121737 @default.
- W3213066087 cites W3115009914 @default.
- W3213066087 cites W3120926490 @default.
- W3213066087 cites W3128276018 @default.
- W3213066087 cites W3129558828 @default.
- W3213066087 cites W3129693855 @default.
- W3213066087 cites W3131995220 @default.
- W3213066087 cites W3133676924 @default.
- W3213066087 cites W3133742235 @default.
- W3213066087 cites W3135749358 @default.
- W3213066087 cites W3136828643 @default.
- W3213066087 cites W3144378969 @default.
- W3213066087 cites W3153528761 @default.
- W3213066087 cites W3155123963 @default.
- W3213066087 cites W3156291144 @default.
- W3213066087 cites W3162006159 @default.
- W3213066087 cites W3163708934 @default.
- W3213066087 cites W3167632857 @default.
- W3213066087 cites W4234318080 @default.
- W3213066087 cites W4235232179 @default.
- W3213066087 doi "https://doi.org/10.3389/fimmu.2021.778829" @default.
- W3213066087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34868052" @default.
- W3213066087 hasPublicationYear "2021" @default.
- W3213066087 type Work @default.
- W3213066087 sameAs 3213066087 @default.
- W3213066087 citedByCount "2" @default.
- W3213066087 countsByYear W32130660872022 @default.
- W3213066087 crossrefType "journal-article" @default.
- W3213066087 hasAuthorship W3213066087A5008985186 @default.
- W3213066087 hasAuthorship W3213066087A5013471175 @default.
- W3213066087 hasAuthorship W3213066087A5022068424 @default.
- W3213066087 hasAuthorship W3213066087A5032957660 @default.
- W3213066087 hasAuthorship W3213066087A5035861839 @default.
- W3213066087 hasAuthorship W3213066087A5041262702 @default.
- W3213066087 hasAuthorship W3213066087A5044612550 @default.
- W3213066087 hasAuthorship W3213066087A5045371240 @default.
- W3213066087 hasAuthorship W3213066087A5048286456 @default.
- W3213066087 hasAuthorship W3213066087A5061875704 @default.
- W3213066087 hasAuthorship W3213066087A5064204310 @default.
- W3213066087 hasAuthorship W3213066087A5065725770 @default.